Who are the women su­per­charg­ing bio­phar­ma R&D? Nom­i­nate them for this year's spe­cial re­port

The biotech in­dus­try has faced re­peat­ed calls to di­ver­si­fy its work­force — and in the last year, those calls got a lot loud­er. Though women ac­count for just un­der half of all biotech em­ploy­ees around the world, they oc­cu­py very few places in C-suites, and even few­er make it to the helm.

Some com­pa­nies are lis­ten­ing, ac­cord­ing to a re­cent BIO sur­vey which showed that this year’s com­pa­nies were 2.5 times more like­ly to have a di­ver­si­ty and in­clu­sion pro­gram com­pared to last year’s sam­ple. But we still have a long way to go. Women rep­re­sent just 31% of biotech ex­ec­u­tives, BIO re­port­ed. And those num­bers are even more stark for women of col­or.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.